📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
ASTRAZENECA PHARMA INDIA LTD.ASTRAZENPharmaceuticals
Open
8800
High
9000
Low
8694
Close
8960.5
Volume
10901
Exchange
nse
Time
10-Feb-2026

Outlook

Score:  

3.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Astrazeneca Pharma India is  
Long Body
Estimated Stoploss of Astrazeneca Pharma India is ₹  
8694
Astrazeneca Pharma India has a  
Bullishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Astrazeneca Pharma India maybe  
Unpredictableℹ
, but keep a lookout for rise in price. 

Trend

Astrazeneca Pharma India is in  
Sideways trendℹ
. 
Price of Astrazeneca Pharma India is  
Upℹ
 by  

3.5

%. 
Target
Buy @ 

8130.38

Sell @ 

9468.88

Current @ 

8960.5

Volume

Astrazeneca Pharma India has seen  
Moderateℹ
 volume of trades. 
Though the volume trend for Astrazeneca Pharma India appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Astrazeneca Pharma India is  

Up

 by  

10.56

% 

Valuation

The current market price of Astrazeneca Pharma India is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 1518cr and total assets worth ₹ 1518cr, the balance sheet of Astrazeneca Pharma India is:  
Balancedℹ
. 
Cashflow
Astrazeneca Pharma India has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 30cr

. It is  
Upℹ
 by  

500

%. 

(*Mar 2025)

40.63% i.e. ₹ 65cr earned in operatingℹ
18.75% i.e. ₹ 30cr earned in investingℹ
40.63% i.e. ₹ 65cr spent in financingℹ
0% in otherℹ
Astrazeneca Pharma India has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 5cr

. It is  
Downℹ
 by  

90.2

%. 

(*Mar 2024)

29.35% i.e. ₹ 27cr earned in operatingℹ
22.83% i.e. ₹ 21cr earned in investingℹ
47.83% i.e. ₹ 44cr spent in financingℹ
0% in otherℹ
Income
The income of Astrazeneca Pharma India is  

₹ 565cr

 and  

Profit

 is :  

₹ 54cr

(*Sep 2025)

Astrazeneca Pharma India Profit is down by:  

1.82

% and Income is Up by:  

5.21

% 

(*Sep 2025)

The income of Astrazeneca Pharma India is  

₹ 537cr

 and  

Profit

 is :  

₹ 55cr

(*Jun 2025)

Astrazeneca Pharma India Profit is down by:  

5.17

% and Income is Up by:  

8.27

% 

(*Jun 2025)

The income of Astrazeneca Pharma India is  

₹ 496cr

 and  

Profit

 is :  

₹ 58cr

(*Mar 2025)

Astrazeneca Pharma India Profit is up by:  

93.33

% and Income is Up by:  

10.71

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.